Category:
Active Pharmaceutical Ingredients
CAS NO:
283173-50-2
Standard:
In-house Standards,
Oncology Ovarian Cancer
Rucaparib (CO-1686) is a potent, oral PARP inhibitor developed for oncology. Its core synthesis involves heterocyclic coupling reactions. Molecular formula: C24H22FN5O2S; CAS No: 906079-38-9.
Strictly store below 25°C in dry, dark conditions. Handle with PPE due to potential genotoxicity. Contraindicated in patients with severe hepatic impairment without dose adjustment protocols.